ALAIR¿
Report
- Report Number
- 3005099803-2015-03615
- Event Type
- Injury
- Date Received
- December 17, 2015
- Date of Event
- April 10, 2015
- Report Date
- November 20, 2015
- Manufacturer
- BOSTON SCIENTIFIC - CORK
- Product Code
- OOY
- PMA / PMN Number
- P080032
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GB
- Reporter Occupation
- PHYSICIAN
Narratives
UPDATED DEVICE LOT NUMBER, DEVICE EXPIRATION DATE, DEVICE MANUFACTURED DATE FOR THE BT CATHETER USED DURING THE RESCHEDULED 3RD BT PROCEDURE PERFORMED ON (B)(6) 2015.
THE COMPLAINANT WAS UNABLE TO PROVIDE THE SUSPECT DEVICE LOT NUMBER; THEREFORE, THE LOT EXPIRATION AND DEVICE MANUFACTURE DATES ARE UNKNOWN. (B)(6) STUDY SOURCE: BSC BT REGISTRY CLINICAL STUDY. THE COMPLAINANT INDICATED THAT THE DEVICE WAS DISPOSED AND WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ALAIR BRONCHIAL THERMOPLASTY (BT) CATHETER WAS USED DURING A BRONCHIAL THERMOPLASTY PROCEDURE ON (B)(6) 2015 AS PART OF THE BSC BT REGISTRY CLINICAL STUDY. THIS COMPLAINT IS BEING REPORTED BASED ON THE EVENT OF MUCUS PLUGGING REQUIRING HOSPITALIZATION AND MEDICAL TREATMENT. ON (B)(6) 2015, DURING PRE-TREATMENT BRONCHOSCOPIC EXAMINATION OF THE AIRWAYS PRIOR TO THE THIRD BT PROCEDURE, A MUCUS PLUG WAS NOTED IN THE LOWER LEFT LOBE OF THE LUNG. THE PLUG WAS SUCTIONED DURING BRONCHOSCOPY AND THE THIRD BT PROCEDURE WAS POSTPONED. THE PATIENT WAS HOSPITALIZED AND TREATED WITH PREDNISOLONE, AS WELL AS DOXYCYCLINE. BRONCHOALVEOLAR LAVAGE FROM THE LOWER LEFT LOBE WAS WEAKLY POSITIVE ON ASPERGILLUS POLYMERASE CHAIN REACTION (PCR), BUT FUNGAL AND BACTERIAL CULTURES WERE NEGATIVE, SUGGESTING THE MUCUS PLUGGING WAS ASTHMATIC RATHER THAN INFECTIVE. THERE WAS NO REPORTED MALFUNCTION OF THE DEVICE. ON (B)(6) 2015, THE PATIENT WAS DISCHARGED FROM THE HOSPITAL AND THE EVENT WAS CONSIDERED TO BE RESOLVED. PRE-BRONCHODILATOR: FEV1: 1.78, FEV1 % PREDICTED: 57.00, FVC: 1.99, FVC % PREDICTED: 55.00. **ADDITIONAL INFORMATION RECEIVED ON 26JUL2016** ON (B)(6) 2015 THE PATIENT UNDERWENT THE RESCHEDULED THIRD BRONCHIAL THERMOPLASTY PROCEDURE TO THE RIGHT AND LEFT UPPER LOBES OF THE LUNGS. NO ISSUES WERE NOTED TO THE DEVICE. ACCORDING TO THE COMPLAINANT, ON (B)(6) 2015, THE PATIENT WAS SEEN IN THE EMERGENCY ROOM (ER) FOR A LOWER RESPIRATORY TRACT INFECTION (LRTI) AND WAS TREATED WITH PREDNISOLONE. NO HOSPITALIZATIONS OCCURRED. ON (B)(6) 2016 THE LOWER RESPIRATORY TRACT INFECTION HAD RESOLVED.
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ALAIR BRONCHIAL THERMOPLASTY (BT) CATHETER WAS USED DURING A BRONCHIAL THERMOPLASTY PROCEDURE ON (B)(6) 2015 AS PART OF THE BSC BT REGISTRY CLINICAL STUDY. THIS COMPLAINT IS BEING REPORTED BASED ON THE EVENT OF MUCUS PLUGGING REQUIRING HOSPITALIZATION AND MEDICAL TREATMENT. ON (B)(6) 2015, DURING PRE-TREATMENT BRONCHOSCOPIC EXAMINATION OF THE AIRWAYS PRIOR TO THE THIRD BT PROCEDURE, A MUCUS PLUG WAS NOTED IN THE LOWER LEFT LOBE OF THE LUNG. THE PLUG WAS SUCTIONED DURING BRONCHOSCOPY AND THE THIRD BT PROCEDURE WAS POSTPONED. THE PATIENT WAS HOSPITALIZED AND TREATED WITH PREDNISOLONE, AS WELL AS DOXYCYCLINE. BRONCHOALVEOLAR LAVAGE FROM THE LOWER LEFT LOBE WAS WEAKLY POSITIVE ON ASPERGILLUS POLYMERASE CHAIN REACTION (PCR), BUT FUNGAL AND BACTERIAL CULTURES WERE NEGATIVE, SUGGESTING THE MUCUS PLUGGING WAS ASTHMATIC RATHER THAN INFECTIVE. THERE WAS NO REPORTED MALFUNCTION OF THE DEVICE. ON (B)(6) 2015, THE PATIENT WAS DISCHARGED FROM THE HOSPITAL AND THE EVENT WAS CONSIDERED TO BE RESOLVED. PRE-BRONCHODILATOR: FEV1: 1.78; FEV1 % PREDICTED: 57.00 ; FVC: 1.99; FVC % PREDICTED: 55.00;
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 834694 | ALAIR¿ | BRONCHIAL THERMOPLASTY SYSTEM | OOY | BOSTON SCIENTIFIC - CORK | M005ATS25020 | 17834211 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 35 YR | Hospitalization| R |